4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-18-054519
Chief Operating Officer acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hogenhuis Wladimir · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-04 | Grant or award : show line 1 in the form | +15,000 | 15,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-10-04 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +75,000 | $77.30 | 2028-10-04 | 75,000 | 75,000 | D |
Loading xslF345X03/doc4.xml…